- Global Pharma News & Resources

Press Releases - 2018-08-24

Date Title Company
24-Aug-2018 Association for the Bladder Exstrophy Community Announces First Eight U.S. "Center of Excellence" Designees PRWeb House E-Commerce
24-Aug-2018 Arkansas Children's Hospital to Acquire TRIUX™ neo for Functional Brain Imaging MEGIN
24-Aug-2018 AT&T, Softbox and Merck Test Connected Payloads and Drone Flights to Deliver Medical Supplies in Puerto Rico AT&T Inc.
24-Aug-2018 Dr. James and Mrs. Ilbra Petros of Allied Pain & Spine Institute to Host Fundraiser for Assyrian Refugees Allied Pain & Spine Institute
24-Aug-2018 Daniel Lyman Ridout III MD, FACP, AGAF, FASGE is recognized by Continental Who's Who Continental Who's Who
24-Aug-2018 MYM Enters Into Research Partnership With the University of Sherbrooke MYM Nutraceuticals Inc.
24-Aug-2018 LGC Capital Updates on the Construction & Expansion Plans at Tricho-Med's Brownsburg, Quebec Cannabis Facility LGC Capital Ltd.
24-Aug-2018 Supreme Cannabis Announces Key Additions to Executive Team The Supreme Cannabis Company, Inc.
24-Aug-2018 U.S. Health and Human Services recognizes and awards local community health centers for providing effective and high quality health care services Health Center Partners of Southern California
24-Aug-2018 Countless Rules for Diets -- FEBC Shares Advice From Weight Loss Journeys Financial Education Benefits Center
24-Aug-2018 Green Leaf Medical Raises $6M Green Leaf Medical, LLC
24-Aug-2018 Clover Health Announces Major Expansion with Plans to Enter Six New Markets in 2019 Clover Health
24-Aug-2018 China Biologic Announces Updates on Unsolicited Acquisition Proposals and Strategic Private Placement China Biologic Products Holdings, Inc.
24-Aug-2018 GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance GT Biopharma Inc.
24-Aug-2018 Magnetic Mark: Scientists Develop an Effective Tool for Cancer Diagnosis and Therapy National University of Science and Technology MISiS
24-Aug-2018 Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema Shire
24-Aug-2018 Immunocore Announces Start of Phase I ImmTAC® Study in Patients with Solid Tumours Immunocore
24-Aug-2018 Evoke Group Simplifies Structure, Unveils New Identity and Vision Evoke Group
24-Aug-2018 Trading update for the financial year ending 30 September 2018 IXICO
24-Aug-2018 COMPASS Pathways receives FDA approval for psilocybin therapy clinical trial for treatment-resistant depression COMPASS Pathways